Links for live webcasts and replays, if available, will be available in the on the "Investors" page of the BBOT website. Replays will be available on the website for at least 90 days following the event. SOUTH SAN FRANCISCO, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. ("BBOT") (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS- pathway malignancies, today announced that members of its leadership team will participate in two investor conferences in S ...